Efficacy of immune checkpoint inhibitors in patients with non-small cell lung cancer harboring ERBB2 exon 20 insertions and non-ERBB2 exon 20 insertions

被引：0
|
作者：
Tu, Hai-Yan
Kai Yin
Ke, E-E
Wu, Si-Pei
Zhao, Xiaotian
Li, Yang-Si
Zheng, Mei-Mei
Liu, Si-Yang Maggie
Sun, Yue-Li
Lin, Jia-Xin
Bai, Xiao-Yan
Zhang, Yi-Chen
Qing Zhou
Yang, Jin-Ji
Zhong, Wenzhao
Wang, Bin-Chao
Zhu, Dongqin
Yang, Lingling
Ou, Qiuxiang
Wu, Yi-Long
机构：
[1] South China Univ Technol, Guangdong Acad Med Sci, Guangdong Lung Canc Inst, Guangdong Prov Peoples Hosp,Sch Med, Guangzhou, Peoples R China
[2] Southern Med Univ, Guangdong Lung Canc Inst, Guangdong Prov Peoples Hosp, Guangdong Acad Med Sci,Sch Clinical Med 2, Guangzhou, Peoples R China
[3] Guangdong Prov Peoples Hosp, Guangdong Acad Med Sci, Guangdong Lung Canc Inst, Guangzhou, Peoples R China
[4] Guangdong Prov Peoples Hosp, Guangdong Acad Med Sci, Guangdong Lung Canc Inst, Guangdong Prov Key Lab Translat Med Lung Canc, Guangzhou, Peoples R China
[5] Nanjing Geneseeq Technol Inc, Geneseeq Res Inst, Nanjing, Peoples R China
[6] Jinan Univ Chinese, Dept Hematol, Sch Med, Affiliated Hosp 1,Inst Hematol,Key Lab Regenerati, Jinan, Peoples R China
[7] Chinese Thorac Oncol Grp CTONG, Guangzhou, Peoples R China
[8] Guangdong Prov Peoples Hosp, Guangdong Lung Canc Inst, Guangzhou, Peoples R China
[9] Guangdong Acad Med Sci, Guangzhou, Peoples R China
[10] Guangdong Prov Peoples Hosp, Dept Guangdong Lung Canc Inst, Guangzhou, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2022年 / 40卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2591
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Infrequent ERBB2 mutations in Chinese patients with non-small cell lung cancer
    Feng, Shuidong
    Ling, Hongyan
    Guo, Hui
    Tong, Lingling
    Hu, Guobin
    Liao, Li
    Lv, Xueying
    Tan, Hongzhuan
    Wu, Yimou
    JOURNAL OF THORACIC DISEASE, 2014, 6 (05) : 503 - 506
  • [42] Immune microenvironment features and efficacy of PD-1/PD-L1 blockade in non-small cell lung cancer patients with EGFR or HER2 exon 20 insertions
    Chen, Kaiyan
    Pan, Guoqiang
    Cheng, Guoping
    Zhang, Fanrong
    Xu, Yanjun
    Huang, Zhiyu
    Fan, Yun
    THORACIC CANCER, 2021, 12 (02) : 218 - 226
  • [43] Clinical Outcome of Non-Small Cell Lung Cancer with EGFR/HER2 Exon 20 Insertions Identified in the LC-SCRUM-Japan
    Udagawa, H.
    Matsumoto, S.
    Ohe, Y.
    Satouchi, M.
    Furuya, N.
    Kim, Y. H.
    Seto, T.
    Soejima, K.
    Hayakawa, D.
    Kato, T.
    Miyamoto, S.
    Ohashi, K.
    Saeki, S.
    Ohta, H.
    Fujimoto, D.
    Sekine, A.
    Yoh, K.
    Goto, K.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S224 - S224
  • [44] EGFR and ERBB2 Exon 20 Insertion Mutations in Chinese Non-small Cell Lung Cancer Patients: Pathological and Molecular Characterization, and First-Line Systemic Treatment Evaluation
    Zhao, Ruiying
    Li, Jiaqi
    Guo, Lianying
    Xiang, Chan
    Chen, Shengnan
    Zhao, Jikai
    Shao, Jinchen
    Zhu, Lei
    Ye, Min
    Qin, Gang
    Chu, Tianqing
    Han, Yuchen
    TARGETED ONCOLOGY, 2024, 19 (02) : 277 - 288
  • [45] EGFR and ERBB2 Exon 20 Insertion Mutations in Chinese Non-small Cell Lung Cancer Patients: Pathological and Molecular Characterization, and First-Line Systemic Treatment Evaluation
    Ruiying Zhao
    Jiaqi Li
    Lianying Guo
    Chan Xiang
    Shengnan Chen
    Jikai Zhao
    Jinchen Shao
    Lei Zhu
    Min Ye
    Gang Qin
    Tianqing Chu
    Yuchen Han
    Targeted Oncology, 2024, 19 : 277 - 288
  • [46] Mutational landscape and characteristics of ERBB2 in non-small cell lung cancer
    Wei, Xue-Wu
    Gao, Xin
    Zhang, Xu-Chao
    Yang, Jin-Ji
    Chen, Zhi-Hong
    Wu, Yi-Long
    Zhou, Qing
    THORACIC CANCER, 2020, 11 (06) : 1512 - 1521
  • [47] Characterization of ERBB2 alterations in non-small cell lung cancer.
    Singh, Vijendra
    Feldman, Rebecca
    Sukari, Ammar
    Kim, Chul
    Mamdani, Hirva
    Spira, Alexander, I
    Bepler, Gerold
    Kim, Edward S.
    Raez, Luis E.
    Pai, Sachin Gopalkrishna
    Ikpeazu, Chukwuemeka
    Vanderwalde, Ari M.
    Xiu, Joanne
    Wozniak, Antoinette J.
    Borghaei, Hossein
    Liu, Stephen, V
    Nagasaka, Misako
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [48] Sensitivity to Immune Checkpoint Blockade in Advanced Non-Small Cell Lung Cancer Patients with EGFR Exon 20 Insertion Mutations
    Metro, Giulio
    Baglivo, Sara
    Bellezza, Guido
    Mandarano, Martina
    Gili, Alessio
    Marchetti, Giovanni
    Toraldo, Marco
    Molica, Carmen
    Reda, Maria Sole
    Tofanetti, Francesca Romana
    Siggillino, Annamaria
    Prosperi, Enrico
    Giglietti, Antonella
    Di Girolamo, Bruna
    Garaffa, Miriam
    Marasciulo, Francesca
    Minotti, Vincenzo
    Gunnellini, Marco
    Guida, Annalisa
    Sassi, Monica
    Sidoni, Angelo
    Roila, Fausto
    Ludovini, Vienna
    GENES, 2021, 12 (05)
  • [49] Mechanisms of resistance to CLN-081 (TAS6417) in non-small cell lung cancer with EGFR exon 20 insertions
    Hayashida, Takuma
    Kagawa, Yosuke
    Mori, Shunta
    Jie, Liu
    Kashima, Yukie
    Tanaka, Kosuke
    Udagawa, Hibiki
    Izumi, Hiroki
    Kobayashi, Susumu
    CANCER RESEARCH, 2022, 82 (12)
  • [50] ERBB2 AND ERBB3 EXPRESSION IN RESECTED NON-SMALL CELL LUNG CANCER (NSCLC) PATIENTS (PTS)
    Freixinos, Victor
    Salcedo, Maite
    Tallada, Natalia
    Murtra-Garrell, Nuria
    Navarro, Alejandro
    Martinez, Pablo
    Cedres, Susana
    Teixido, Cristina
    Hernandez-Losa, Javier
    Lopez, Eva
    Montero, M. A.
    Peg, Vicente
    Pallisa, Esther
    Canela, Mercedes
    Felip, Enriqueta
    Ramon Y Cajal, Santiago
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S1063 - S1064
12345